RecTech
29 posts


Beyond #CRISPR: Felix Lansing @tudresden_de hat ein neues molekulares Skalpell zur Behandlung genetischer Krankheiten entwickelt. Für seine Promotion erhält er den Deutschen #Studienpreis 2022. Herzlichen Glückwunsch @felix_lansing! koerber-stiftung.de/projekte/deuts…



#WeeklyUpdate Startup-Woche 16-2022: 🚀 38 neue #Startups 🌷 24% #FemaleFounders 💸 34 Startups mit frischem #VentureCapital 🎉 Unsere Neugründungen der Woche: @RecTech_Dresden 🎉 Unser Investment der Woche: ununu.io



It was a pleasure to present our research in the annual meeting of the German Society for Gene Therapy (DG-GT) 🧬@DGGTeV #GeneTherapy

It was a great pleasure to present our recently published paper (nature.com/articles/s4146…) at the 66th @AnnualGth 2022. It was my first talk in person since more than 2 years! Thanks for the great event! Work from: @BuchholzLab_TUD @TakebeLab @Medizin_TUD @digsbb @tudresden_de






Today the @ESGCT Virtual Congress will start! I am excited to hear about many new approaches from the fields of gene and cell therapy! On top, I will give my very first talk at a scientific conference on Thursday at 5.30pm CEST! #esgct2021 #recombinases #GeneTherapy


Another five #startups pitched their innovative ideas to renowned investors at the LIFE SCIENCE PITCH DAY.💯Great pitches by: RecTec, @OPSYON_CD47, Invasight, Riana Therapeutics and Dimericon. #HTGF #LifeScience #PitchDay @Bayer, @BoehringerDE, IZB













